Cystic Fibrosis is said to be the most common deadly genetic disease that is suffered by Canadian children and young adults.

However, a drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could reduce the risk of cystic fibrosis, according to Researchers at McMaster University

They stated that it is an effective way to deal with anti-biotic resistance to bacterial infections, which is the case of those with cystic fibrosis.

Eric Brown, Professor and Chair of McMaster's Department of Biochemistry and Biomedical Sciences, has stated that Antibiotic resistance have profound effects on known drugs that are used to treat illness and disease, as infectious organisms are increasingly resisting antibiotics.

The discovery was made by Brown with the assistance of McMaster researchers Gerry Wright and Brian Coombes.

They discovered that combining the two drugs will retard the growth of the bacteria, after the analysis of previously approved anti-biotic in the university's Centre for Microbial Chemical Biology.

Cystic Fibrosis Canada and its partner in funding the project, the Canadian Institutes of Health Research, have stated that the findings could have a major impact as anti-biotic resistant bacteria threatened the whole wide-world.

Also, the findings have created an avenue for the discovery of the effects of combined drugs.